Navigation Links
New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders

Data to be Presented April 15th at EASL Conference in Barcelona, Spain

VANCOUVER and SAN DIEGO, CA, April 11, 2007 /PRNewswire-FirstCall/ - MIGENIX Inc. , a clinical-stage developer of drugs for infectious diseases, has received new top-line results confirming the previously announced clinical results (November 6, 2006) indicating evidence of clinical benefit, safety and tolerability in a Phase II study using the oral alpha-glucosidase inhibitor, celgosivir (MX-3253), in combination with pegylated interferon and ribavirin.

In addition to confirming the overall conclusions of the original study analysis, retesting resulted in a larger percentage of patients achieving an Early Virologic Response(x) ("EVR") rate with celgosivir plus peginterferon alfa-2b and ribavirin (the "triple combination") as compared to treatment with peginterferon alfa-2b and ribavirin alone (the "control treatment") in patients with chronic hepatitis C virus genotype 1 infections who were characterized as non-responders to prior therapy with optimized pegylated interferon plus ribavirin, achieving:

    -   42% (5/12) EVR with the celgosivir triple combination arm compared to

        10% (1/10) EVR in the control treatment arm. This compares with 33%

        (4/12) EVR (triple combination) vs 10% (1/10) (control treatment) in

        the original study results. (x) EVR = 2 log(10) or greater

        HCV viral load reduction at 12 weeks.


    -   1.63 log(10) (triple combination) mean HCV viral load reduction

        ("VLR") compared to a 0.92 log(10) VLR (control treatment). This

        compares with a 1.2 log(10) VLR (triple combination) vs a 0.4 log(10)

        VLR (control treatment) in the original study results.


    -   a more rapid onset of treatment effect as measured by VLR within the

        first 2 weeks of therapy in the triple combination as compared to the

        control treatment.

Thes
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
Post Your Comments:
(Date:1/15/2014)... , Jan. 15, 2014 AARP Foundation today ... to support older adults suffering from the severe cold ... and its members are committed to helping those in ... and AARP Foundation will match dollar-for-dollar contributions up to ... The matching program will be administered through AARP Foundation. ...
(Date:1/15/2014)... WORTH, Texas , Jan. 15, 2014  Humberto ... in Dermatology Achievement Award" from the Journal of ... Dermatology Aesthetic & Clinical Conference (ODAC). The event is January ... Florida . The ... report on the practice of dermatology for clinical and ...
(Date:1/15/2014)... 15, 2014 MultiCell Technologies, Inc. (OTC Bulletin ... provisional patent application concerning composition of matter, biological targets, ... tumor cell death.  This patent application ... stranded RNA molecules (VSRNAs) which interfere with the basic ... molecular size less than 10 bps, yet are surprisingly ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
... As part of a three-year global initiative to identify ... problems around the world, Boehringer Ingelheim and Ashoka,s Changemakers® ... Health: Achieving Individual, Family, and Community Well-Being ... the most innovative models and solutions that are transforming ...
... England, July 6, 2011 , Vantia ... targeting large areas of,unmet medical need, today announces it ... series B round. The round was co-led by Novo ... Partners, all,existing investors in Vantia. The funds have been ...
Cached Medicine Technology:Boehringer Ingelheim and Ashoka's Changemakers Launch "Making More Health" Competition 2Boehringer Ingelheim and Ashoka's Changemakers Launch "Making More Health" Competition 3Vantia Therapeutics Raises £4 Million to Fund Clinical Development of its Lead Compounds 2Vantia Therapeutics Raises £4 Million to Fund Clinical Development of its Lead Compounds 3
(Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight ... behavior issues in other areas of the world, which ... that could lead to successful interventions. , A ... United Nations mentions that due to the HIV/AIDS pandemic, ... African, children are at an increased risk for mental ...
(Date:4/14/2014)... A new study shows that moderate to severe ... risk of stroke, cancer and death. , Results of ... to severe obstructive sleep apnea were four times more ... times more likely to have a stroke (HR = ... (HR = 3.4), and 2.5 times more likely to ...
(Date:4/14/2014)... Dallas study involving serious youth offenders, the answer to one ... seven years: "How long do you think you,ll live?", According ... offending over time., Author Dr. Alex Piquero said the study ... of them offend at very high rates and commit more ... much later in life offend much less., "In a lot ...
(Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
(Date:4/14/2014)... Lower weight babies and babies who aren,t breastfed ... risk of developing chronic inflammation and related health ... study. , "There were good reasons to hypothesize ... inflammation in adulthood," says Thomas McDade (Northwestern University), ... in the Child & Brain Development program. "It ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2Health News:Low birth weight, less breastfeeding create later health risks 2
... Rochester optics professor Jannick Rolland has developed an optical ... The aim of the technology is to detect and ... or cancerous without having to cut the suspected tumor ... lab. Instead, the tip of a roughly one-foot-long cylindrical ...
... CA Knee pain related to osteoarthritis (OA) is ... athletes, especially former NFL players, but researchers presenting their ... Specialty Day program (February 19th) say they have a ... patients who were obese with early-onset knee osteoarthritis showed ...
... treatment using microfracture for pediatric knee injury repair may ... American Orthopaedic Society for Sports Medicine,s Specialty Day in ... are able to regain function and return to a ... "Our study focused on patients with articular cartilage injuries ...
... hernias are commonly found in individuals with a mechanical disorder ... fix the hip disorder alone in some cases, according to ... for Special Surgery, will be presented at the American Orthopedic ... 19 in San Diego following the annual meeting of the ...
... DALLAS Feb. 17, 2011 Low levels of ... warning sign of the presence of kidney disease and ... Southwestern Medical Center researchers. Using mice, investigators found ... of chronic kidney disease (CKD), improves when Klotho hormone ...
... , FRIDAY, Feb. 18 (HealthDay News) -- Children as young as ... a study that finds practice is more important than age in ... 221 children aged 5 to 10 years. The largest increases in ... and 7 and ages 8 and 9. Performance appears to plateau ...
Cached Medicine News:Health News:A new high-resolution method for imaging below the skin using a liquid lens 2Health News:Weight loss improves knee pain from common arthritic condition, study says 2Health News:Study shows young patients may benefit from microfracture knee procedures 2Health News:Common hip disorder can cause sports hernia 2Health News:Common hip disorder can cause sports hernia 3Health News:Anti-aging hormone Klotho may prevent complications 2
Fine pointed grooved jaws with smooth curve from tip to finger grip style handle. Dull finish....
Inner jaw space 2.0 mm - 45 degree tip angulation. 20 gauge (.89 mm) diameter shaft and stationary distal jaw. Lightweight squeeze handle with dull finish. Jaws 1.5 mm serrated....
Straight shafts with 5.5 mm tying platform and 45 degree 0.3 mm teeth. Wide serrated handle with polished finish....
Straight shafts with 1 x 2 teeth. Flat handle with polished finish....
Medicine Products: